Q2 Solutions has one of the largest networks of wholly owned, CAP accredited central laboratories with a presence in the Americas, Europe, Asia and Africa, including dedicated bioanalytical, ADME, genomics and specialty laboratories. Our Pretoria, South Africa facility was established in 1999 and is a full service clinical central laboratory with a full range of capabilities to meet global requirements while delivering tailored solutions for studies conducted in Africa. The Q2 Solutions lab in South Africa has developed specialized capabilities to support infectious disease studies, including tuberculosis studies. Our biosafety level 3 lab and innovative clinical trial delivery models have been designed to better support tuberculosis and infectious disease studies around the world. Download our factsheet to learn more.